Hyperphagia

2 trials MedDRA PT
2 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

2 trials
  • Acadia Pharmaceuticals Inc. Commercial
    CARBETOCIN
    2023-506200-24-00 5 countries 2025 n=98
    Ended
  • Acadia Pharmaceuticals Inc. Commercial
    CARBETOCIN
    2023-506201-19-00 3 countries 2025 n=48
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Acadia Pharmaceuticals Inc. Commercial 2 Phase III 0
New trials by year
2025
2
← All indication landscapes